Gavish Galilee Bioapplications

Gavish Galilee Bioapplications is the commercialization subsidiary of MIGAL Galilee Research Institute, based in Kiryat Shmona in northern Israel. The firm funds applied science in immunology, precision agriculture, and regional bio-convergence, drawing deal flow primarily from MIGAL’s research output. This is closer to a tech-transfer vehicle than a standalone VC, and founders should understand the relationship with the underlying institute is structural rather than incidental.

Stages are Pre-Seed and Seed, with check sizes under $250,000. Sub-verticals are biotech and pharma, although the institute’s broader work in precision agriculture means non-clinical agtech may also be in scope. The record does not list named portfolio companies. Activity is concentrated in Israel, particularly the Galilee region.

For founders, the most relevant pathway is via existing MIGAL research relationships. Teams without an institute connection will find the entry point harder. Healthcare AI founders working in immunology, particularly with a wet-lab or applied-science angle that ties to MIGAL’s research themes, are the closest match. Pure software AI without a biology anchor is unlikely to fit. The small check size means this is a research-translation seed at best, and founders will need a follow-on syndicate to reach meaningful operational scale. Geographic willingness to engage with the Galilee region is essentially required.